(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.00%) $0.927
(-0.07%) $10.83
(-0.09%) $0.792
(-0.21%) $92.38
Live Chart Being Loaded With Signals
Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally...
Stats | |
---|---|
Today's Volume | 196 575 |
Average Volume | 179 696 |
Market Cap | 1.73B |
EPS | €0 ( 2024-02-18 ) |
Next earnings date | ( €0 ) 2024-05-12 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -41.32 |
ATR14 | €0.00800 (0.10%) |
Volume Correlation
Almirall, S.A. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Almirall, S.A. Correlation - Currency/Commodity
Almirall, S.A. Financials
Annual | 2023 |
Revenue: | €898.80M |
Gross Profit: | €581.40M (64.69 %) |
EPS: | €-0.200 |
Q4 | 2023 |
Revenue: | €428.46M |
Gross Profit: | €159.07M (37.13 %) |
EPS: | €-0.240 |
Q2 | 2023 |
Revenue: | €234.73M |
Gross Profit: | €208.66M (88.89 %) |
EPS: | €0.0652 |
Q1 | 2023 |
Revenue: | €232.50M |
Gross Profit: | €152.20M (65.46 %) |
EPS: | €0.0424 |
Financial Reports:
No articles found.
Almirall, S.A.
Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators